Nutrition Research
Volume 26, Issue 4 , Pages 154-162 , April 2006

Nutritional support of pediatric patients with cancer consuming an enteral formula with fructooligosaccharides

  • Shan Zheng

      Affiliations

    • Fundan University, Children's Hospital, Department of Surgery, 183 Fenglin Road, Shanghai 200032, China
    • ,
  • Philippe Steenhout

      Affiliations

    • Nestlé Nutrition, Nestec Ltd., 32 Av Reller, Vevey 1800, Switzerland
    • ,
  • Dong Kuiran

      Affiliations

    • Fundan University, Children's Hospital, Department of Surgery, 183 Fenglin Road, Shanghai 200032, China
    • ,
  • Wang Qihong

      Affiliations

    • Fundan University, Children's Hospital, Department of Surgery, 183 Fenglin Road, Shanghai 200032, China
    • ,
  • Wang Weiping

      Affiliations

    • Fundan University, Children's Hospital, Department of Surgery, 183 Fenglin Road, Shanghai 200032, China
    • ,
  • Corinne Hager

      Affiliations

    • Nestlé Research Centre, Nestec Ltd., Lausanne 1000, Switzerland
    • ,
  • Ferdinand Haschke

      Affiliations

    • Nestlé Nutrition, Nestec Ltd., 32 Av Reller, Vevey 1800, Switzerland
    • ,
  • Roger A. Clemens

      Affiliations

    • USC School of Pharmacy, 1985 Zonal Ave, Los Angeles, CA 90089-9121, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 323 442 2124; fax: +1 323 442 1499.

Received 25 October 2005 ,Revised 25 March 2006 ,Accepted 10 April 2006.

References 

  1. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer. 1998;34:503–509
  2. ReyFerro M, Castano R, Orozco O, Serna A, Moreno A. Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition. 1997;13:878–881
  3. Hochwald SN, Harrison LE, Heslin MJ, Burt ME, Brennan MF. Early postoperative enteral feeding improves whole body protein kinetics in upper gastrointestinal cancer patients. Am J Surg. 1997;174:325–330
  4. Bachmann P, Gordiani B, Ranchere J-Y, Lallemand Y, Combret D, Latour J-F, et al. Évaluation de l'indication et de la qualité de la prise en chage nutritionnelle en cancérologie médicale. Nutr Clin Métab. 1998;12:3–11
  5. Sikora S, Ribeiro U, Kane JM, Landreneau RJ, Lembersky B, Posner M. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. J Parenter Enteral Nutr. 1997;282:18–21
  6. Scrimshaw NS, San Giovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:S464–S477
  7. Schattner M. Enteral nutrition support of the patient with cancer: route and role. J Clin Gastroenterol. 2003;36:297–302
  8. Gianotti L, Braga M, Vignali A, Balzano G, Zerbi A, Bisagni P, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg. 1997;132:1222–1230
  9. Georgieff M, Tugtekin IF. Positive role of immune nutrition on metabolism in sepsis and multi-organ failure. Kidney Int. 1998;53:S80–S83
  10. Scioscia KA, Snyderman CH, Wagner R. Altered serum amino acid profiles in head and neck cancer. Nutr Cancer. 1998;30:144–147
  11. Shankardass K, Chuchmach S, Chelswick K, Stefanovich C, Spurr S, Brooks J, et al. Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. J Parenter Enteral Nutr. 1990;14:508–512
  12. Liebl BH, Fischer MH, Van Calcar SC, Marlett JA. Dietary fiber and long-term large bowel response in enterally nourished nonambulatory profoundly retarded youth. J Parenter Enteral Nutr. 1990;14:371–375
  13. Hartemink R, VanLaere KM, Rombouts FM. Growth of enterobacteria on fructo-oligosaccharides. J Appl Microbiol. 1997;83:367–374
  14. Alles MS, Katan MB, Salemans JM, VanLaere KM, Gerichhausen MJ, et al. Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch-anal anastomosis. Am J Clin Nutr. 1997;66:1286–1292
  15. Roberfroid MB. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr. 1993;33:103–148
  16. Jiang T, Savaiano DA. Modification of colonic fermentation by bifidobacteria and pH in vitro: impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci. 1997;42:2370–3277
  17. Taber HS, Roberfroid M. Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr. 1999;129:1488S–1491S
  18. Taber HS, Roberfroid MB. Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer. 2001;38:1–5
  19. Axford J. Glycobiology and medicine: an introduction. J R Soc Med. 1997;90:260–264
  20. Kok N, Roberfroid M, Robert A, Delzenne N. Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr. 1996;76:881–890
  21. Buddington RK, Williams CH, Chen SC, Witherly SA. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr. 1996;63:709–716
  22. Hague A, Diaz GD, Hicks DJ, Krajweski S, Reed JC, Paraskeva C. bcl-2 and bak may play a pivotal role in sodium butyrate–induced apoptosis in colonic epithelial cells; however, overexpression of bcl-2 does not protect against bak-medicated apoptosis. Int J Cancer. 1997;72:898–905
  23. Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis. 2001;22:43–47
  24. Sanders BG, Kline K. Nutrition, immunology and cancer: an overview. In:  Longenecker JB,  Kritchevsky D,  Drezner MK editor. Nutrition and biotechnology in heart disease and cancer. New York: Springer-Verlag; 1995;p. 185–194
  25. Guigoz Y, Rochat F, Perrisseau-Carrier G, Rochat I, Schiffrin EJ. Effects of oligosaccharide on fecal flora and non-specific immune system in elderly people. Nutr Res. 2002;22:13–25
  26. Pressac M, Vignoli L, Aymard P, Ingenbleek Y. Usefulness of a prognostic inflammatory and nutritional index in pediatric clinical practice. Clin Chim Acta. 1990;188:129–136
  27. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. CDC Growth Charts: United States. Adv Data 2000;314:1-28.
  28. Taber HS, Roberfroid MB. Inulin/oligofructose and anticancer therapy. Br J Nutr. 2002;87:S283–S286
  29. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr. 1999;39:13–126
  30. Kudlackova M, Andel M, Hajkova H, Novakova J. Follow-up of burn injuries using the PINI index. Rozhl Chir. 1989;68:595–599
  31. Bartolome LML, Garcia VC, Ruiz-Echarri ZMP, Calvo Ruata ML, Baldellou VA. Evaluation of the nutritional state in patients with congenital cardiopathy. An Esp Pediatr. 1991;35:185–188
  32. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985;55:91–101
  33. Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer. 2003;11:60–62
  34. Guigoz Y, Rochat F, Perruisseau-Carrier G, Rochat I, Schiffrin EJ. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr Res. 2002;22:13–25
  35. Saavedra JM, Tschernia A. Human studies with probiotics and prebiotics: clinical implications. Br J Nutr. 2002;87:S241–S246
  36. Barshop BA, Nyhan WL, Steenhout PH, Endres W, Tolan DR, Clemens RA. Fructo-oligosaccharide tolerance in patients with hereditary fructose intolerance. A preliminary non-randomized open challenge short-term study. Nutr Res. 2003;23:1003–1011

PII: S0271-5317(06)00054-6

doi: 10.1016/j.nutres.2006.04.001

Nutrition Research
Volume 26, Issue 4 , Pages 154-162 , April 2006

Article Tools

* Image Usage & Resolution